Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Calidi Biotherapeutics Inc CLDI

Alternate Symbol(s):  CLDWW

Healthcare Biotechnology
Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's novel stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Its clinical-stage off-the-shelf... see more

Recent & Breaking News (NYSEAM:CLDI)

Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer

GlobeNewswire 6 days ago

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

GlobeNewswire 9 days ago

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

GlobeNewswire 10 days ago

Calidi Biotherapeutics Announces Proposed Public Offering

GlobeNewswire 11 days ago

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

GlobeNewswire 12 days ago

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Accesswire October 25, 2024

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

GlobeNewswire October 24, 2024

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

GlobeNewswire October 23, 2024

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)

GlobeNewswire October 18, 2024

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Accesswire October 18, 2024

Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma

GlobeNewswire September 30, 2024

Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

GlobeNewswire August 13, 2024

GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Accesswire August 2, 2024

Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

GlobeNewswire July 29, 2024

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform

GlobeNewswire July 18, 2024

Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board

GlobeNewswire July 16, 2024

Calidi to Effect Reverse Stock Split

Business Wire July 5, 2024

Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors

Business Wire June 27, 2024

Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13

Business Wire June 11, 2024

Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi's Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors

Business Wire June 10, 2024